OFEV® (nintedanib) time to face IPF head on A common enemy: The impact of ILDs Document ID: PC-ZA-102103 05/05/2023 Author: Boehringer Ingelheim Progression waits for no one RELATED CONTENT PC-ZA-102103 Production date: May 2023
